"Institut je osnovan Dekretom vlade Narodne Republike Srbije 1950. godine, sa ciljem organizovanja i razvijanja nacionalne mreže zdravstvenih institucija namenjenih ženama generativnog doba, predškolskoj i školskoj deci. Odlukom Ministarstva zdravlja Srbije iz 1993. i 1995. godine, Institut postaje nacionalna referentna ustanova za zdravstvenu zaštitu ovih populacionih grupa. Institut čini sedam organizacionih celina: PEDIJATRIJSKA KLINIKA KLINIKA ZA DEČJU HIRURGIJU SLUŽBA ZA HUMANU REPRODUKCIJU REPUBLIČKI CENTAR ZA PLANIRANjE PORODICE SLUŽBA ZA NAUČNO-ISTAŽIVAČKU I OBRAZOVNU DELATNOST SLUŽBA ZA ORGANIZACIJU, PLANIRANjE, EVALUACIJU I MEDICINSKU INFORMATIKU SLUŽBA ZA NEMEDICINSKE POSLOVE"

During the past decade, Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic" conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 6 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" #1 sponsor was "Pfizer" with 3 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 3 trials sponsored, "Takeda" with 3 trials sponsored, "Institute for Mother and Child Health Care of Serbia "Dr Vukan Cupic"" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" #1 collaborator was "Alberta Children's Hospital" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Child and Family Research Institute" with 1 trials as a collaborator, "Simon Fraser University" with 1 trials as a collaborator and "The Hospital for Sick Children" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" are "Hemophilia A" (3 trials), "Dravet Syndrome (DS)" (2 trials), "Epilepsy, Partial Seizures" (2 trials), "Hemophilia B" (2 trials) and "Lennox Gastaut Syndrome (LGS)" (2 trials). Many other conditions were trialed in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" in a lesser frequency.

Most popular intervention types in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" are "Drug" (12 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Soticlestat" (3 trials), "PF-06741086" (2 trials), "BIIB017 (peginterferon beta-1a)" (1 trials) and "Edoxaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"" are 13 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic"". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mother and Child Health Care Institute of Serbia "Dr Vukan Cupic", 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".